Investigator-Sponsored Research
 Program
Overview
Submission
Process
Frequently Asked Questions
  

Investigator-Sponsored Research Program

The Investigator-Sponsored Research (ISR) Program represents an important portion of medical research. The ISR Program serves as a conduit between Boston Scientific and external researchers to expand research.

Boston Scientific provides support for research that advances medical and scientific knowledge about our products and that generates medical interventions. This global program is open to all qualified researchers who are interested in conducting their own research

SUBMIT A GRANT REQUEST


After reading the Submission Process, log-in to submit or edit your proposal

ASK A QUESTION


If you still have questions after reading over the Frequently Asked Questions (FAQs), please reach out to us

Research Areas

Each Boston Scientific division reviews research requests for a variety of topics pertaining to Boston Scientific products and associated disease states.

We are currently looking at research in the following areas:

Interventional Cardiology/Structural Heart Topics of Interest

TAVR: Lotus Edge and Acurate

  • Efficacy in Complex Cases, Unique Aortic Anatomies and subpopulations
  • Embolic protection
  • Health Economics Analysis
     

Watchman

  • Imaging
  • Health Economics Data
  • Blood thinner comparative data
  • Subgroup analysis
     

Complex PCI

  • FFR, iFR, DFR usage
  • Health Economics and Efficiency Analysis
     

Stents and Balloons

  • Agent and Synergy applications and sub-population data
     
Back to top

Peripheral Interventions Topics of Interest

  • New/emerging Technologies
  • Health Economics and/or Quality of Life
  • Comparative-Effectiveness
  • Geographic variation in device use
     
Back to top

Rhythm & Electrophysiology Topics of Interest

  • Cardiac mapping
  • Cardiac ablation
  • Subcutaneous ICD
  • Heart failure
  • Left atrial appendage closure
     
Back to top

Endoscopy/Airway Topics of Interest

  • Gastro
  • Biliary
  • Snares
  • polypectomy
  • Severe asthma and bronchial thermoplasty (BT)
    • BT – patient selection and markers of response and/or safety.
    • Severe asthma – natural history.
  • Bronchial thermoplasty in practice
    • Case studies demonstrating safety and efficacy of BT.
    • Procedure optimization.
    • Clinical experience in patients with characteristics such as:
      • Low FEV1
      • Elderly
      • Occupational asthma
      • Allergic and non-allergic asthma
      • Asthma with concomitant use of immunomodulatory agents
      • Asthma with a COPD component.
    • Patient satisfaction data.
    • Clinical outcome data such as impact on medication usage.
  • Bronchial thermoplasty mechanism of action
    • Evaluate the impact of BT on airway remodeling, inflammation, and hyperresponsiveness.
    • Assess impact on asthma pathophysiology.
    • Identification of biomarkers for patient responders
    • Further definition of patient responders. 
       
Back to top

Urology and Pelvic Health Topics of Interest

Urolithiasis

  • Treatment outcomes in upper tract urinary stone disease
     

BPH

  • Treatment outcomes and QoL in BPH
     

Cancer

  • Spacing and marking for radiation in various anatomies
     

Female Stress Urinary Incontinence

  • The case for minislings as standard of care therapy for stress urinary incontinence
    • Patient experience
    • Economics
  • A systematic review and meta-analysis of the safety and efficacy of urinary slings for treating female stress urinary incontinence
  • Incidence of complications following sling surgery in high risk women (obesity, medical comorbidities, concomitant hysterectomy etc.)
  • Learning curve for Solyx
     

Pelvic Floor Reconstruction

  • Use of Capio in native tissue repair for prolapse
  • Safety and efficacy of Y- mesh implanted by transabdominal route
     

Removal of Uterine Tissue

  • A meta-analysis of the safety and efficacy of Symphion in treating fibroids
     

Male Stress Urinary Incontinence

  • AUS / AdVance XP vs comparative device studies
    • Patient and/or Caregiver satisfaction/experience
    • Performance & treatment outcomes
  • Economics of Incontinence
    • Coping costs (i.e. pads/laundry/pills)
    • Economic impact on society
    • Patient productivity
    • Mental health
  • Benefit of diagnosing Incontinence
    • Cardiovascular
    • Diabetes
    • Obesity
  • Female AUS studies


Male Erectile Dysfunction (ED)

  • AMS 700 / Tactra vs other competitive devices
    • Patient and/or Partner satisfaction/experience
    • Performance & treatment outcomes
  • Economics of ED
    • Cost effectiveness of IPP as first line therapy
    • Coping costs (i.e. alternative erectile dysfunction solutions)
    • Economic impact on society
    • Patient productivity
    • Mental health
  • Benefits of diagnosing ED
    • Cardiovascular
    • Diabetes
    • Obesity
 
Back to top

Neuromodulation Topics of Interest

  • Spinal Cord Stimulation
    • Treatment of chronic, intractable pain of the back and legs using the Spectra WaveWriter™ SCS System
      • Of particular interest:
        • Efficacy of combination therapy
        • Programming optimization
        • Contour™ field shaping algorithm vs other field shapes
        • Anatomical vs paresthesia-based neural targeting
  • Deep Brain Stimulation
    • Treatment of Parkinson’s Disease and other movement disorders using Vercise™ Deep Brain Stimulation System
      • Of particular interest:
        • Freezing of gait
        • Replacement of other DBS systems with Vercise DBS System
        • Use of multiple frequencies on one lead
        • Use of current fractionalization to maximize overlap with desired structures and minimize stimulation of non-target tissue
        • Novel targets for Parkinson’s Disease, Dystonia, Tremor (may require IDE)

Back to top

How the U.S. Physician Payment Sunshine Act Impacts Sponsored Researchers

The U.S. Physician Payment Sunshine Act requires all pharmaceutical, biologic and medical device manufacturers – like Boston Scientific – to report annually to the U.S. government payments and transfers of value made to U.S. physicians and teaching hospitals. This could include educational and research grants and charitable donations. 

Read additional details about the U.S. Physician Payment Sunshine Act

 

Top